Acadian Asset Management LLC Surmodics Inc Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$25.39 - $42.1 $155,361 - $257,609	-6,119 Reduced 1.5%	402,660 $16.9 Million
Q1 2024 May 10, 2024	BUY	$27.44 - $35.56 $1.14 Million - $1.48 Million	41,617 Added 11.33%	408,779 $12 Million
Q4 2023 Feb 13, 2024	BUY	$28.47 - $38.49 $353,711 - $478,199	12,424 Added 3.5%	367,162 $13.3 Million
Q3 2023 Nov 13, 2023	BUY	$28.28 - $38.36 $1.58 Million - $2.15 Million	56,012 Added 18.75%	354,738 $11.4 Million
Q2 2023 Aug 07, 2023	BUY	$17.67 - $31.31 $304,860 - $540,191	17,253 Added 6.13%	298,726 $9.35 Million
Q1 2023 May 11, 2023	BUY	$17.13 - $38.52 $966,080 - $2.17 Million	56,397 Added 25.06%	281,473 $6.41 Million
Q4 2022 Feb 14, 2023	SELL	$29.44 - $37.31 $291,102 - $368,921	-9,888 Reduced 4.21%	225,076 $7.68 Million
Q3 2022 Nov 14, 2022	SELL	$28.84 - $38.92 $238,103 - $321,323	-8,256 Reduced 3.39%	234,964 $7.14 Million
Q2 2022 Aug 09, 2022	SELL	$33.25 - $45.11 $1.56 Million - $2.11 Million	-46,853 Reduced 16.15%	243,220 $9.06 Million
Q1 2022 May 12, 2022	SELL	$40.68 - $49.72 $1.58 Million - $1.93 Million	-38,792 Reduced 11.8%	290,073 $13.1 Million
Q4 2021 Feb 10, 2022	SELL	$43.21 - $57.6 $962,070 - $1.28 Million	-22,265 Reduced 6.34%	328,865 $15.8 Million
Q3 2021 Nov 12, 2021	SELL	$52.8 - $60.32 $60,561 - $69,187	-1,147 Reduced 0.33%	351,130 $19.5 Million
Q2 2021 Aug 11, 2021	BUY	$51.29 - $59.15 $1.11 Million - $1.28 Million	21,575 Added 6.52%	352,277 $19.1 Million
Q1 2021 May 11, 2021	BUY	$42.18 - $56.07 $4,091 - $5,438	97 Added 0.03%	330,702 $18.5 Million
Q4 2020 Feb 11, 2021	BUY	$35.18 - $43.52 $25,505 - $31,552	725 Added 0.22%	330,605 $14.4 Million
Q3 2020 Nov 09, 2020	SELL	$37.98 - $48.72 $632,101 - $810,846	-16,643 Reduced 4.8%	329,880 $12.8 Million
Q2 2020 Aug 12, 2020	SELL	$31.07 - $44.74 $262,355 - $377,784	-8,444 Reduced 2.38%	346,523 $15 Million
Q1 2020 May 11, 2020	BUY	$22.46 - $42.24 $1.05 Million - $1.97 Million	46,675 Added 15.14%	354,967 $11.8 Million
Q4 2019 Feb 06, 2020	BUY	$39.01 - $47.51 $2.17 Million - $2.65 Million	55,696 Added 22.05%	308,292 $12.8 Million
Q3 2019 Nov 07, 2019	BUY	$38.66 - $47.41 $402,102 - $493,111	10,401 Added 4.29%	252,596 $11.6 Million
Q2 2019 Aug 08, 2019	SELL	$38.23 - $47.43 $612,253 - $759,591	-16,015 Reduced 6.2%	242,195 $10.5 Million
Q1 2019 May 09, 2019	BUY	$41.26 - $58.35 $310,605 - $439,258	7,528 Added 3.0%	258,210 $11.2 Million
Q4 2018 Feb 07, 2019	SELL	$44.93 - $73.38 $28,934 - $47,256	-644 Reduced 0.26%	250,682 $11.8 Million
Q3 2018 Oct 30, 2018	BUY	$56.85 - $80.35 $5.53 Million - $7.81 Million	97,191 Added 63.06%	251,326 $18.8 Million
Q2 2018 Jul 24, 2018	BUY	$35.85 - $57.05 $1.41 Million - $2.24 Million	39,277 Added 34.2%	154,135 $8.51 Million
Q1 2018 Apr 12, 2018	SELL	$27.0 - $38.5 $342,522 - $488,411	-12,686 Reduced 9.95%	114,858 $4.37 Million
Q4 2017 Jan 18, 2018	SELL	$28.0 - $33.2 $27,272 - $32,336	-974 Reduced 0.76%	127,544 $3.57 Million
Q3 2017 Oct 13, 2017	BUY	$24.5 - $31.1 $3.15 Million - $4 Million	128,518	128,518 $3.99 Million

Others Institutions Holding SRDX

# of Institutions

126

Shares Held

12M

Call Options Held

1.4K

Put Options Held

8.6K

Black Rock Inc. New York, NY

1.17M
Shares

$44.6 Million
0.0% of portfolio
Alliancebernstein L.P. New York, NY

1.04M
Shares

$39.6 Million
0.01% of portfolio
Beryl Capital Management LLC Redondo Beach, CA

989K
Shares

$37.7 Million
14.09% of portfolio
Vanguard Group Inc Valley Forge, PA

804K
Shares

$30.6 Million
0.0% of portfolio
Morgan Stanley New York, NY

753K
Shares

$28.7 Million
0.0% of portfolio

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $533M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account